Andalusian registry for familial adenomatous polyposis. Analysis of patients included;Registro Andaluz de la Poliposis Adenomatosa Familiar. Análisis de los pacientes incluidos

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 11, 2010, Pages 653-657

  Benavides, M Garzón ^a   Moreno, A Pizarro ^a   Lozano, R García ^a   Garrido, M I Herrero ^b   Molina, A J Hervás ^c   Galán, J L Márquez ^a   Fernandez, C Cordero ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL DE JEREZ   (Spain)

^c Hospital Universitario Reina Sofia Cordoba   (Argentina)

Author keywords

APC gene; Familial adenomatous polyposis; FAP registry; Genetic counseling; Genetic study; Genotype; Hereditary cancer; Phenotype

Indexed keywords

ADENOMATOUS POLYP; ADOLESCENT; ADULT; ARTICLE; CODON; COLORECTAL CANCER; DESMOID TUMOR; FAMILIAL POLYPOSIS; GENE MUTATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PIGMENT EPITHELIUM; REGISTER; RETINA MALFORMATION; SCREENING;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; CHILD; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; REGISTRIES; SPAIN; YOUNG ADULT;

EID: 79251476256     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Morton DG, Macdonald F, Haydon J, Cullen R, Barker G, Hulten M, et al. Screening practice for familial adenomatous polyposis: the potential for regional registers. Br J Surg 1993; 80: 255-8.
2. Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 1995; 76: 2427-33.
3. Elizabeth Half, Dani Bercovich and Paul Rozen. Familial adenomatous polyposis. Orphaned J Rare Dis 2009; 4: 22.
4. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Srg 1998; 85: 742-50
5. Brosens LA, Keller JJ, Offerhaus GJ, Goggins M, Giardiello FM. Prevention and management of duodenals polyps in Familial Adenomatous Polyposis. Gut 2005; 54: 1034-43.
6. Morpurgo E, Vitale C, Galandiuk S, Kimberling J, Ziegler C, Polk HC Jr. Clinical characteristics of Familial Adenomatous Polyposis and Management of duodenal adenomas. J. Gastointest Surg 2004; 8(5): 559-64
7. Griffioen G, Bus PJ, Vasen HF, Verspaget HW, Lamers CB. Extracolonie manifestations of familial adenomatous polyposis: desmoids tumors, and upper gastrointestinal adenomas and carcinomas. Scand J Gastroenterol Suppl 1998; 225: 85-91.
8. Olry De Labry Lima A, Sordo del Castillo L, Garcia Mochon L, Epstein D, Bermudez Tamayo C, Villegas Portero R. An economic assessment of genetic testing for familial adenomatous polyposis. Rev Esp Enferm Dig 2008; 100(8): 470-5.
9. Giardello FM, Bresinger JD, Peterson GM, Luce MC, Hylind LM, Bacon JA, et al. The use and interpretation of comercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997; 336: 823-7.
10. Femández-Suárez A, Cordero-Fernández C, García Lozano R, Pizarro A, Garzón M, Núñez Roldan A. Implicaciones clínicas y éticas del consejo genético en la poliposis adenomatosa familiar. Rev Esp Enferm Dig 2005 ; 97(9): 654-65.
11. Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer Registries in The United States: the State of the Union. Dis Colon Rectum 2004; 47: 674-8.
12. Obrador A, Thomson JPS. El Registro de Poliposis del Hospital de San Marcos de Londres. Gastroenterol Hepatol 2002; 25(4): 267-71.
13. Spiegelman AD, Thomson JP. Introduction, history and registries in familial adenomatous polyposis. London, Edward Arnold, 2004.
14. Bussey HJR. St Mark's Hospital Polyposis Register. Annual Report St Mark's Hospital 1970: 20-1.
15. Lockhart-Mummery P. Cancer and Heredity. Lancet 1925; 1:427-9.
16. Reyes Moreno J, Ginard Vicens D, Vanrell M, Marino Z, Garau I, Llompart A, Obrador Adrover A. Mejoría de la supervivencia de la poliposis adenomatosa familiar después del establecimiento de un registro. Med Clin (Bare). 2007; 129(2): 51-2.
17. Bülow S, Vulgo C, Faurschou Nielsen T, Karlsen & Moesgaard L. Centralized Registration, Prophylactic examination and treatment results in improved prognosis in familial adenomatous polyposis. Scand J Gastroenterol 1995; 30: 989-93.
18. Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001; 48: 515-21.
19. Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T, et al. Familial adenomatous polyposis: desmoids tumors and lack of ophthalmic lesions (CHRPE) associated with APC mutation beyond codon 1444. Hum Mol Genet 1995; 4: 337-40.
20. Enomoto M, Konishi M, Iwama T, Utsunomiya J, Sugihara K, Miyaki M. The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. JPN J Clin Oncol 2000; 30(2): 82-8.
21. Crabtree MD, Tomlison IMP, Hodgson SV, Neale K, Phillips RKS, Houlston RS. Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut 2002; 51:420-3.
22. Kashiwagi H, Spigelman AD. Gastroduodenal lesions in familial adenomatous polyposis. Surg Today 2000; 30: 675-82.
23. Jalving M, Koornstra J, Götz J, Van der Waaij LA, de Jong S, Zwart N, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Eur Journal of Gastroent and Hepatol 2003; 15: 1229-33.
24. Hofgärtner W, Thorp M, Ramus M, Delorefice G, Chey WY, Ryan CK, et al. Gastric adenocarcinoma associated with fundic gland polyps in patient with attenuated familial adenomatous polyposis. Am Journal of Gastroenterology 1999; 94: 2275-81.
25. Cordero-Fernández C, Garzón-Benavides M, Pizarro-Moreno A, García-Lozano R, Márquez-Galán JL, López-Ruiz T, et al. Gastroduodenal involvement in patients with familial adenomatous polyposis. Prospective study of the nature and evolution of polyps: evaluation of the treatment and surveillance methods applied. Eur J Gastroenterol Hepatol 2009; 21 (10): 1161-7.
26. Vasen HFA, Möslein G, Alonso A, Aretz S, Berstein I, Bertario L, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57: 704-13.
27. Pikaar A, Notier JW, Griffioen G, Vasen HF. Desmoids tumors in patients with familial adenomatous polyposis. Ned Tijdschr Geneeskd 2002;. 146: 1355-9.
28. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E.. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639-42.
29. Nieuwenhuis MH, Vasen HFA. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007; 61: 153-61.
30. Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Möslein G, et al. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gen. Hum Mutat 2004; 24(5): 370-80.